Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franz Grehn

Showing results (41-50 of 64) with videos related to

Pageof 7
Sort By:
Clinical Ophthalmology (Auckland, N.Z.)|March 21, 2015
A comparative study of a modified filtering trabeculotomy and conventional trabeculectomyJuliane Matlach, Matthias Hipp, Martin Wagner, et al.
BMC Ophthalmology|January 23, 2021
Correction to: First observation of secondary childhood glaucoma in Coffin-Siris syndrome: a case report and literature reviewHeidi Diel, Can Ding, Franz Grehn, et al.
Deutsches Arzteblatt International|May 25, 2016
The Prevalence of Visual Impairment in Retirement Home ResidentsLuisa Thederan, Susanne Steinmetz, Sabine Kampmann, et al.
F1000Research|June 16, 2021
Retrospective evaluation of two-year results with a filtering trabeculotomy in comparison to conventional trabeculectomy by exact matchingAlicja Strzalkowska, Peter Strzalkowski, Yousef Al Yousef, et al.
Investigative Ophthalmology & Visual Science|October 27, 2006
Contractility as a prerequisite for TGF-beta-induced myofibroblast transdifferentiation in human tenon fibroblastsTobias Meyer-ter-Vehn, Sonja Sieprath, Barbara Katzenberger, et al.
Ophthalmology|August 28, 2007
Factors affecting the outcome of trabeculectomy: an analysis based on combined data from two phase III studies of an antibody to transforming growth factor beta2, CAT-152, Franz Grehn, Gábor Holló, et al.
Ophthalmology|October 3, 2007
A phase III study of subconjunctival human anti-transforming growth factor beta(2) monoclonal antibody (CAT-152) to prevent scarring after first-time trabeculectomy, Peng Khaw, Franz Grehn, et al.
Investigative Ophthalmology & Visual Science|January 4, 2008
Substrate rigidity modulates cell matrix interactions and protein expression in human trabecular meshwork cellsGünther Schlunck, Hong Han, Thomas Wecker, et al.
Journal of Glaucoma|July 3, 2018
Catheter-assisted 360-Degree Trabeculotomy for Congenital GlaucomaAnani P Toshev, Martin M Much, Thomas Klink, et al.
Investigative Ophthalmology & Visual Science|March 28, 2006
p38 inhibitors prevent TGF-beta-induced myofibroblast transdifferentiation in human tenon fibroblastsTobias Meyer-Ter-Vehn, Susanne Gebhardt, Walter Sebald, et al.
Pageof 7

Showing results (41-50 of 64) with videos related to

Sort By:
Pageof 7
Clinical Ophthalmology (Auckland, N.Z.)|March 21, 2015
A comparative study of a modified filtering trabeculotomy and conventional trabeculectomyJuliane Matlach, Matthias Hipp, Martin Wagner, et al.
BMC Ophthalmology|January 23, 2021
Correction to: First observation of secondary childhood glaucoma in Coffin-Siris syndrome: a case report and literature reviewHeidi Diel, Can Ding, Franz Grehn, et al.
Deutsches Arzteblatt International|May 25, 2016
The Prevalence of Visual Impairment in Retirement Home ResidentsLuisa Thederan, Susanne Steinmetz, Sabine Kampmann, et al.
F1000Research|June 16, 2021
Retrospective evaluation of two-year results with a filtering trabeculotomy in comparison to conventional trabeculectomy by exact matchingAlicja Strzalkowska, Peter Strzalkowski, Yousef Al Yousef, et al.
Investigative Ophthalmology & Visual Science|October 27, 2006
Contractility as a prerequisite for TGF-beta-induced myofibroblast transdifferentiation in human tenon fibroblastsTobias Meyer-ter-Vehn, Sonja Sieprath, Barbara Katzenberger, et al.
Ophthalmology|August 28, 2007
Factors affecting the outcome of trabeculectomy: an analysis based on combined data from two phase III studies of an antibody to transforming growth factor beta2, CAT-152, Franz Grehn, Gábor Holló, et al.
Ophthalmology|October 3, 2007
A phase III study of subconjunctival human anti-transforming growth factor beta(2) monoclonal antibody (CAT-152) to prevent scarring after first-time trabeculectomy, Peng Khaw, Franz Grehn, et al.
Investigative Ophthalmology & Visual Science|January 4, 2008
Substrate rigidity modulates cell matrix interactions and protein expression in human trabecular meshwork cellsGünther Schlunck, Hong Han, Thomas Wecker, et al.
Journal of Glaucoma|July 3, 2018
Catheter-assisted 360-Degree Trabeculotomy for Congenital GlaucomaAnani P Toshev, Martin M Much, Thomas Klink, et al.
Investigative Ophthalmology & Visual Science|March 28, 2006
p38 inhibitors prevent TGF-beta-induced myofibroblast transdifferentiation in human tenon fibroblastsTobias Meyer-Ter-Vehn, Susanne Gebhardt, Walter Sebald, et al.
Pageof 7